Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
GLP-1 Medications Aid in Reducing Asthma Episodes in Overweight or Obese Teens - Featured image
Health

GLP-1 Medications Aid in Reducing Asthma Episodes in Overweight or Obese Teens

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 4, 2026·2 min read

On this page

  • Key Findings from the Study
  • Potential Dual Advantages
  • Reduction in Medication Needs
  • Role of Weight Reduction
  • Link Between Obesity and Asthma
  • Benefits for Those Struggling with Hunger

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

A recent study reveals that GLP-1 medications can significantly decrease severe asthma episodes among adolescents who are overweight or obese. Researchers found a notable reduction in emergency room visits and steroid use. Experts suggest these drugs offer dual benefits for weight control and asthma management.

Share

On this page

  • Key Findings from the Study
  • Potential Dual Advantages
  • Reduction in Medication Needs
  • Role of Weight Reduction
  • Link Between Obesity and Asthma
  • Benefits for Those Struggling with Hunger

Key Findings from the Study

A current investigation indicates that innovative weight-reduction medications, including Ozempic and Zepbound, are capable of halving severe asthma flare-ups in adolescents carrying excess weight.

Researchers announced on December 29 in JAMA Network Open that teenagers using a GLP-1 medication required half as many emergency room treatments for asthma compared to those not on such drugs.

Potential Dual Advantages

The research group, under the guidance of Dr. Lin-Shien Fu, head of pediatric nephrology and immunology at Taichung Veterans General Hospital in Taiwan, stated that their results point to a possible combined benefit for this demographic. A single category of drug might tackle both weight regulation and decreased chances of asthma worsening, thus easing the load from two frequent and related long-term health issues.

Over a 12-month monitoring period, children on a GLP-1 drug experienced eight asthma-linked emergency visits, while those without weight-loss medication had 19 such incidents.

Reduction in Medication Needs

Adolescents on GLP-1 drugs were also less inclined to use steroids for asthma control, with 21% doing so versus 31% in the comparison group. Additionally, they needed rescue inhalers less frequently, at 32% compared to 45%.

Role of Weight Reduction

Dr. Michelle Katzow, director of the POWER Kids Weight Management Program and an associate professor of pediatrics at Cohen Children's Medical Center in New York City, noted that the loss of weight in these young people probably played a key role in enhancing their asthma condition.

She remarked in a news statement that the outcome isn't entirely unexpected, though the extent of weight loss triggered by the medication surpasses previous observations.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Link Between Obesity and Asthma

Katzow explained that excess body weight leads to bodily inflammation, which heightens the risk of asthma episodes.

She further elaborated that obesity-related inflammation makes individuals more prone to intensified asthma or aggravated symptoms.

If sufficient weight can be shed through any method, it could lessen the intensity of asthma, she added.

Benefits for Those Struggling with Hunger

Katzow emphasized that such medications are most effective for individuals facing difficulties in embracing healthy habits due to overwhelming appetite.

This is particularly relevant for many children, she said, who experience constant hunger and preoccupation with food, making it challenging to opt for nutritious choices or reduce intake when perpetually famished.

Health tracking apps like Shotlee can help monitor these changes in weight and asthma symptoms over time.

Source Information

Originally published by MedicineNet.Read the original article →

Read next

Keep exploring

Same topic: GLP-1 drugs

All GLP-1 drugs articles →
Popular Weight-Loss Drugs Ozempic and Wegovy May Slow Biological Aging
Medical Research

Popular Weight-Loss Drugs Ozempic and Wegovy May Slow Biological Aging

A new clinical trial suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may help slow biological processes associated with aging in adults with HIV.

8 min read
Yes, GLP-1s Make You Thinner. But Do They Make You Freer?
Health & Wellness

Yes, GLP-1s Make You Thinner. But Do They Make You Freer?

While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.

8 min read
Ozempic and Similar Weight-Loss Medications Linked to 30% Lower Breast Cancer Risk
Health & Wellness

Ozempic and Similar Weight-Loss Medications Linked to 30% Lower Breast Cancer Risk

A major study from Penn Medicine reveals a potential link between GLP-1 medications like Ozempic and a significant reduction in breast cancer risk, offering new hope for preventive care.

7 min read

More in Health

Obesity Medications: How They Might Transform the GLP-1 Sector
Health

Obesity Medications: How They Might Transform the GLP-1 Sector

The GLP-1 market, initially dominated by weekly injections, is entering a new phase with the introduction of obesity pills. These oral options from Novo Nordisk and Eli Lilly promise greater convenience and possibly lower costs, attracting new users and reshaping the industry. Analysts predict significant market growth, with pills capturing a substantial share by 2030.

9 min read
WHO Issues New Advice on GLP-1 Weight Loss Medications: Key Points
Health

WHO Issues New Advice on GLP-1 Weight Loss Medications: Key Points

The World Health Organization (WHO) has provided new guidance on using GLP-1 drugs like Ozempic and Wegovy for obesity. The recommendations include considerations for adults and highlight the importance of lifestyle changes alongside medication.

2 min read
Ozempic-like Medications: New Alert Issued Over Suicidal Thought Risk
Health

Ozempic-like Medications: New Alert Issued Over Suicidal Thought Risk

Australia's Therapeutic Goods Administration (TGA) has issued a safety alert concerning Ozempic-style drugs and a potential connection to suicidal thoughts and behaviors. While a direct causal link hasn't been established, the TGA advises patients to immediately inform their healthcare provider if they experience any changes in mood or behavior.

4 min read
Share this article
  1. Home
  2. Blog
  3. GLP-1 Medications Aid in Reducing Asthma Episodes in Overweight or Obese Teens
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community